Deal Making

signing contract

Pharma

ALS med Radicava to change hands as Shionogi inks $2.5B buyout

Shionogi plans to leverage the U.S. commercial platform inherited in the buy for several future launches.

Eric Sagonowsky Dec 22, 2025 10:10am

The Top Line

The biopharma dealmaking landscape and what to expect in 2026

Dec 5, 2025 11:10am